Clinical Study

[Retracted] Amodiaquine-Artesunate versus Artemether-Lumefantrine against Uncomplicated Malaria in Children Less Than 14 Years in Ngaoundere, North Cameroon: Efficacy, Safety, and Baseline Drug Resistant Mutations in pfcrt, pfmdr1, and pfdhfr Genes

Table 1

Study participant’s characteristics at enrolment.

CharacteristicAS/AQ ( )AL ( ) value

Sex
 Male39 (53.4)39 (50.6)0.73
 Female34 (46.6)38 (49.4)
Age (years)
 Mean ± SD 0.98
 Range01.0–13.001.0–13.0
Weight (kg)
 Mean ± SD 0.52
 Range07.0–41.006.0–35.0
Temperature (°C)
 Mean ± SD 0.80
 Range31.1–40.535.5–39.8
Haemoglobin (g/dL)
 Mean ± SD 0.55
 Range4.8–28.04.9–17.8
Anaemia
 (Hb < 9.5 g/dL)21/73 (28.8)26/77 (33.8)0.51
Parasitaemia (/μL)
 GMPD4628.303886.360.18
 Range1340–184 0001240–156 000

SD: standard deviation, GMPD: geometric mean parasite density, and numbers in brackets represent percentages. There were no significant differences between baseline characteristics for participants randomised in both treatment arms.